| Profile | GDS5420 / 224642_at |
| Title | Psoriasis response to brodalumab: dose response and time course |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM1296094 | A_lesional_pre-dose | 113.85 | 44 |
| GSM1296119 | B_lesional_pre-dose | 618.96 | 71 |
| GSM1296076 | C_lesional_pre-dose | 732.41 | 75 |
| GSM1296092 | D_lesional_pre-dose | 393.39 | 64 |
| GSM1296103 | E_lesional_pre-dose | 225.32 | 55 |
| GSM1296078 | F_lesional_pre-dose | 624.88 | 72 |
| GSM1296107 | G_lesional_pre-dose | 688.17 | 73 |
| GSM1296109 | H_lesional_pre-dose | 677.81 | 73 |
| GSM1296080 | I_lesional_pre-dose | 95.48 | 42 |
| GSM1296090 | J_lesional_pre-dose | 560.25 | 70 |
| GSM1296074 | K_lesional_pre-dose | 588.03 | 71 |
| GSM1296111 | L_lesional_pre-dose | 953.56 | 79 |
| GSM1296099 | M_lesional_pre-dose | 228.07 | 54 |
| GSM1296086 | O_lesional_pre-dose | 397.16 | 64 |
| GSM1296117 | P_lesional_pre-dose | 831.32 | 76 |
| GSM1296113 | Q_lesional_pre-dose | 920.7 | 78 |
| GSM1296096 | R_lesional_pre-dose | 279.86 | 58 |
| GSM1296105 | S_lesional_pre-dose | 184.79 | 50 |
| GSM1296098 | T_lesional_pre-dose | 111.67 | 42 |
| GSM1296101 | U_lesional_pre-dose | 159.94 | 48 |
| GSM1296121 | V_lesional_pre-dose | 564.59 | 70 |
| GSM1296088 | W_lesional_pre-dose | 205.4 | 53 |
| GSM1296082 | X_lesional_pre-dose | 658.76 | 73 |
| GSM1296115 | Y_lesional_pre-dose | 991.2 | 79 |
| GSM1296084 | Z_lesional_pre-dose | 126.63 | 45 |
| GSM1296072 | B_lesional_day8 | 380.38 | 63 |
| GSM1296069 | L_lesional_day8 | 925.24 | 78 |
| GSM1296071 | P_lesional_day8 | 592.23 | 70 |
| GSM1296070 | Y_lesional_day8 | 705.8 | 73 |
| GSM1296073 | V_lesional_day8 | 635.28 | 72 |
| GSM1296034 | A_lesional_day15 | 44.77 | 28 |
| GSM1296041 | G_lesional_day15 | 1086.7 | 81 |
| GSM1296035 | R_lesional_day15 | 186.29 | 52 |
| GSM1296038 | U_lesional_day15 | 276.19 | 58 |
| GSM1296047 | B_lesional_day15 | 381.97 | 63 |
| GSM1296039 | E_lesional_day15 | 480.09 | 68 |
| GSM1296042 | H_lesional_day15 | 740.9 | 74 |
| GSM1296043 | L_lesional_day15 | 690.72 | 73 |
| GSM1296037 | M_lesional_day15 | 121.08 | 43 |
| GSM1296046 | P_lesional_day15 | 764.66 | 75 |
| GSM1296044 | Q_lesional_day15 | 729 | 74 |
| GSM1296045 | Y_lesional_day15 | 624 | 71 |
| GSM1296025 | C_lesional_day15 | 162.11 | 49 |
| GSM1296033 | D_lesional_day15 | 214.78 | 54 |
| GSM1296027 | I_lesional_day15 | 75.85 | 40 |
| GSM1296032 | J_lesional_day15 | 174.21 | 50 |
| GSM1296024 | K_lesional_day15 | 133.16 | 47 |
| GSM1296031 | W_lesional_day15 | 188.24 | 50 |
| GSM1296028 | X_lesional_day15 | 184.75 | 51 |
| GSM1296029 | Z_lesional_day15 | 125.96 | 45 |
| GSM1296026 | F_lesional_day15 | 189 | 52 |
| GSM1296030 | O_lesional_day15 | 127.21 | 48 |
| GSM1296040 | S_lesional_day15 | 167.85 | 49 |
| GSM1296036 | T_lesional_day15 | 158.28 | 47 |
| GSM1296048 | V_lesional_day15 | 509.7 | 68 |
| GSM1296059 | A_lesional_day43 | 172.56 | 51 |
| GSM1296066 | G_lesional_day43 | 869.07 | 77 |
| GSM1296060 | R_lesional_day43 | 212.46 | 53 |
| GSM1296063 | U_lesional_day43 | 518.25 | 69 |
| GSM1296064 | E_lesional_day43 | 589.85 | 71 |
| GSM1296067 | H_lesional_day43 | 358.92 | 61 |
| GSM1296062 | M_lesional_day43 | 120.94 | 44 |
| GSM1296068 | Q_lesional_day43 | 588.35 | 70 |
| GSM1296050 | C_lesional_day43 | 307.91 | 60 |
| GSM1296057 | D_lesional_day43 | 124.06 | 45 |
| GSM1296052 | I_lesional_day43 | 90.27 | 42 |
| GSM1296054 | J_lesional_day43 | 96.87 | 40 |
| GSM1296049 | K_lesional_day43 | 114.75 | 44 |
| GSM1296055 | W_lesional_day43 | 178.96 | 50 |
| GSM1296053 | X_lesional_day43 | 96.86 | 41 |
| GSM1296058 | Z_lesional_day43 | 89.43 | 41 |
| GSM1296051 | F_lesional_day43 | 331.39 | 62 |
| GSM1296056 | O_lesional_day43 | 226.74 | 55 |
| GSM1296065 | S_lesional_day43 | 402.09 | 64 |
| GSM1296061 | T_lesional_day43 | 113.64 | 43 |
| GSM1296095 | A_non-lesional_pre-dose | 260.52 | 57 |
| GSM1296120 | B_non-lesional_pre-dose | 450.14 | 66 |
| GSM1296077 | C_non-lesional_pre-dose | 158.73 | 49 |
| GSM1296093 | D_non-lesional_pre-dose | 129.04 | 44 |
| GSM1296104 | E_non-lesional_pre-dose | 345.33 | 62 |
| GSM1296079 | F_non-lesional_pre-dose | 157.12 | 49 |
| GSM1296108 | G_non-lesional_pre-dose | 471.74 | 67 |
| GSM1296110 | H_non-lesional_pre-dose | 543.46 | 68 |
| GSM1296081 | I_non-lesional_pre-dose | 61.08 | 36 |
| GSM1296091 | J_non-lesional_pre-dose | 318.6 | 61 |
| GSM1296075 | K_non-lesional_pre-dose | 393.83 | 65 |
| GSM1296112 | L_non-lesional_pre-dose | 612.19 | 71 |
| GSM1296100 | M_non-lesional_pre-dose | 90.98 | 39 |
| GSM1296087 | O_non-lesional_pre-dose | 93.83 | 43 |
| GSM1296118 | P_non-lesional_pre-dose | 609.76 | 71 |
| GSM1296114 | Q_non-lesional_pre-dose | 794.87 | 76 |
| GSM1296097 | R_non-lesional_pre-dose | 199.09 | 52 |
| GSM1296106 | S_non-lesional_pre-dose | 214.87 | 53 |
| GSM1296102 | U_non-lesional_pre-dose | 100.16 | 40 |
| GSM1296122 | V_non-lesional_pre-dose | 341.44 | 61 |
| GSM1296089 | W_non-lesional_pre-dose | 183.49 | 50 |
| GSM1296083 | X_non-lesional_pre-dose | 137.99 | 46 |
| GSM1296116 | Y_non-lesional_pre-dose | 777.53 | 75 |
| GSM1296085 | Z_non-lesional_pre-dose | 81.2 | 38 |